Genetics and Molecular Biology (Aug 2019)

Osteogenesis imperfecta in Brazilian patients

  • Maira Trancozo,
  • Marcos V.D. Moraes,
  • Dalila A. Silva,
  • Jéssica A.M. Soares,
  • Clara Barbirato,
  • Márcio G. Almeida,
  • Lígia R. Santos,
  • Maria R. G. O. Rebouças,
  • Akel N. Akel Jr,
  • Valentim Sipolatti,
  • Vanda R. R. Nunes,
  • Flavia I. V. Errera,
  • Meire Aguena,
  • Maria R. Passos-Bueno,
  • Flavia de Paula

DOI
https://doi.org/10.1590/1678-4685-gmb-2018-0043
Journal volume & issue
Vol. 42, no. 2
pp. 344 – 350

Abstract

Read online Read online

Abstract Osteogenesis Imperfecta (OI) is a heterogeneous genetic disorder characterized by bone fragility and fracture. Mutations in 20 distinct genes can cause OI, and therefore, the genetic diagnosis of OI is frequently difficult to obtain because of the great number of genes that can be related with this disease. Studies that report the most frequently mutated genes in OI patients can help to improve molecular strategies for diagnosis of the disease. In order to characterize the mutation profile of OI in Brazilian patients, we analyzed 30 unrelated patients through SSCP screening, NGS gene panel, and/or Sanger sequencing for the 11 most frequently mutated genes in the database of mutations, including COL1A1, COL1A2, P3H1, CRTAP, PPIB, SERPINH1, SERPINF1, FKBP10, SP7, WNT1 and IFITM5. Disease-causing variants were identified in COL1A1, COL1A2, FKBP10, P3H1, and IFITM5. A total of 28 distinct mutations were identified, including seven novel changes. Our data show that the analysis of these five genes is able to detect at least 95% of causative mutations in OI disorder from Brazilian population. However, it has to be taken into considerations that distinct populations can have different frequencies of disease-causing variants. Hence, it is important to replicate this study in other groups.

Keywords